Olgun, M. Et Al. 2019. Zoledronic acid improves bone mineral density in beta-thalassemia patients with osteoporosis: a case control study. CUKUROVA MEDICAL JOURNAL , vol.44, no.3 , 882-890.

Olgun, M., GÜRKAN, E., & TULİ, A., (2019). Zoledronic acid improves bone mineral density in beta-thalassemia patients with osteoporosis: a case control study. CUKUROVA MEDICAL JOURNAL , vol.44, no.3, 882-890.

Olgun, MEHTAP, EMEL GÜRKAN, And ABDULLAH TULİ. "Zoledronic acid improves bone mineral density in beta-thalassemia patients with osteoporosis: a case control study," CUKUROVA MEDICAL JOURNAL , vol.44, no.3, 882-890, 2019

Olgun, MEHTAP Et Al. "Zoledronic acid improves bone mineral density in beta-thalassemia patients with osteoporosis: a case control study." CUKUROVA MEDICAL JOURNAL , vol.44, no.3, pp.882-890, 2019

Olgun, M. GÜRKAN, E. And TULİ, A. (2019) . "Zoledronic acid improves bone mineral density in beta-thalassemia patients with osteoporosis: a case control study." CUKUROVA MEDICAL JOURNAL , vol.44, no.3, pp.882-890.

@article{article, author={MEHTAP EVRAN Et Al. }, title={Zoledronic acid improves bone mineral density in beta-thalassemia patients with osteoporosis: a case control study}, journal={CUKUROVA MEDICAL JOURNAL}, year=2019, pages={882-890} }